Dr. Maximilian Schwab~~Miriam Steets~~Dr. Bettina Bokeloh~~Martin Waskowski~~Dr. Tobias Gerigk~~Dr. Johanna Blumenthal~~Dr. Maximilian Schatz
January 24, 2026
Willkie Advises Adiuva Capital on Strategic Capital Increase for Sanecum Group

1 min
AI-made summary
- Willkie advised Adiuva Capital on an equity funding as part of a EUR 250 million strategic capital increase for Sanecum Group, involving several long-term equity investors led by Montana Capital Partners and a bank syndicate
- Sanecum operates a network of medical care centers in Germany, specializing in internal medicine
- The capital increase aims to support Sanecum's growth in the outpatient market
- The Willkie team was led by Dr
- Maximilian Schwab and Miriam Steets.
Willkie advised Adiuva Capital in connection with an equity funding as part of a EUR 250 million strategic capital increase for Sanecum Group by several long-term equity investors led by Montana Capital Partners as well as a bank syndicate.
Sanecum is a leading, physician-managed network of medical care centers in Germany with over 200 physicians and more than 800 employees. The centers focus on internal medicine, including nephrology, cardiology and the areas of diagnostics and laboratory medicine.
The capital increase will enable Sanecum to continue its successful growth strategy in the outpatient market.
Adiuva is a leading investor focused on mid-market companies primarily based in German-speaking countries.
The Willkie team was led by partners Dr. Maximilian Schwab and Miriam Steets, and included partner Dr. Bettina Bokeloh, counsel Martin Waskowski, and associates Dr. Maximilian Hirsch, Dr. Tobias Gerigk, Dr. Johanna Thieme and Dr. Maximilian Schatz.
Article Author
Dr. Maximilian Schwab~~Miriam Steets~~Dr. Bettina Bokeloh~~Martin Waskowski~~Dr. Tobias Gerigk~~Dr. Johanna Blumenthal~~Dr. Maximilian Schatz
The Sponsor
